46 related articles for article (PubMed ID: 2137370)
1. Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.
Simcik W; Sheu TL; LeGrue SJ
Cancer Immunol Immunother; 1989; 30(4):219-26. PubMed ID: 2598191
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.
Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
Cancer Immunol Immunother; 1994 Jun; 38(6):372-8. PubMed ID: 8205558
[TBL] [Abstract][Full Text] [Related]
3. Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity.
Aukerman SL; Fidler IJ
Cancer Immunol Immunother; 1987; 25(3):175-9. PubMed ID: 2824050
[TBL] [Abstract][Full Text] [Related]
4. Protection against metastasis by immunization with an allogeneic lymphocyte antigen.
Egawa K; Seo N; Tanino T; Tsukiyama T
Cancer Immunol Immunother; 1995 Dec; 41(6):384-8. PubMed ID: 8635196
[TBL] [Abstract][Full Text] [Related]
5. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.
Okada F; Hosokawa M; Hasegawa J; Ishikawa M; Chiba I; Nakamura Y; Kobayashi H
Cancer Immunol Immunother; 1990; 31(6):358-64. PubMed ID: 2386981
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. II. T cell response after induction of immunogenicity.
Zöller M
Cancer Immunol Immunother; 1985; 19(3):189-97. PubMed ID: 2408743
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.
Ding LN; Yoshida T; Isobe K; Rahman SM; Nagase F; Yokochi T; Kawashima K; Nakashima I
Jpn J Cancer Res; 1991 Jul; 82(7):841-7. PubMed ID: 1679057
[TBL] [Abstract][Full Text] [Related]
8. The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.
Killion JJ; Radinsky R; Dong Z; Fishbeck R; Whitworth P; Fidler IJ
Cancer Immunol Immunother; 1993 Jun; 36(6):381-6. PubMed ID: 8098991
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
[TBL] [Abstract][Full Text] [Related]
10. Purification of immunoprotective tumor antigens by preparative isotachophoresis.
Saunders TL; Kahan BD; Pellis NR
Cancer Immunol Immunother; 1983; 16(2):101-8. PubMed ID: 6559101
[TBL] [Abstract][Full Text] [Related]
11. Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.
Yamashina K; Oikawa T; Kasai M; Naiki M; Chiba I; Kobayashi H
Cancer Immunol Immunother; 1986; 21(1):45-50. PubMed ID: 3632916
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic humoral immune responses to tumor-associated antigens expressed by K-1735 UV-induced melanoma and its metastases.
Thistlethwaithe P; Davidson DD; Fidler IJ; Roth JA
Cancer Immunol Immunother; 1983; 15(1):11-6. PubMed ID: 6553502
[TBL] [Abstract][Full Text] [Related]
13. Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum.
Tanino T; Seo N; Okazaki T; Nakanishi-Ito C; Sekimata M; Egawa K
Cancer Immunol Immunother; 1992; 35(4):230-6. PubMed ID: 1380893
[TBL] [Abstract][Full Text] [Related]
14. The effect of purification on the immunogenicity of tumor-specific transplantation antigens.
Saunders TL; Kahan BD; Pellis NR
Cancer Immunol Immunother; 1985; 19(1):22-7. PubMed ID: 3844971
[TBL] [Abstract][Full Text] [Related]
15. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
16. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
17. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
18. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.
Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN
Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244
[TBL] [Abstract][Full Text] [Related]
19. MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
Ward PL; Schreiber H
Semin Cancer Biol; 1991 Oct; 2(5):321-8. PubMed ID: 1837738
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
